Weixiang Kong
Jining First People's Hospital(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, SARS-CoV-2 and COVID-19 Research, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer(2018)54 cited
- → Up-regulated circular RNA VANGL1 contributes to progression of non-small cell lung cancer through inhibition of miR-195 and activation of Bcl-2(2019)38 cited
- → miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR(2019)29 cited
- → Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT(2024)12 cited
- → Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19(2024)7 cited
- → Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial(2025)2 cited
- → Olgotrelvir as a Standalone Treatment for Nonhospitalized COVID-19 Patients (MPR-COV-301CN): A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial(2024)